Oral cancer is one of the few cancers dentists see coming and still, too often, catch too late. Most cases are visible during a routine exam, yet nearly 3 in 4 aren’t identified until a late stage, when five-year survival drops from roughly 88% to just 37%. The problem isn’t awareness. It’s that dental teams […]
OraLiva Partners with Rovers Medical Devices to Expand Clinical Applications of the Orcellex® with Oral Cancer Screening Test
OraLiva is pleased to announce a collaboration with Rovers Medical Devices, a global leader in medical sampling devices, to support the OraLiva’s AI-powered oral cytology test. As part of the collaboration, OraLiva will utilize Rovers’ Orcellex® brush technology, which is designed to collect high-quality transepithelial cellular samples. These samples are then analyzed using OraLiva’s advanced […]
Delta Dental of Michigan, Delta Dental of North Carolina and OraLiva Inc. Announce Multi-State Launch of AI-Powered Oral Cancer Test
New collaboration covers non-invasive cytology and AI risk-stratification to dentists across Michigan, Ohio, Indiana, and North Carolina Durham, NC — January 15th, 2026 — Delta Dental Plan of Michigan, Inc. Delta Dental Plan of Ohio, Inc., Delta Dental Plan of Indiana, Inc., (collectively “DDMI”) and Delta Dental of North Carolina(“DDNC”)[1] have reaffirmed their commitment to […]


